Enfusion reports Q4 adjusted EPS 4c, consensus 5c

Reports Q4 revenue $46.49M, consensus $45.27M. The company said, “I’m pleased to share that Enfusion ended 2023 with excellent financial performance and increased momentum as we start 2024. Our results demonstrate our ability to navigate a challenging macroeconomic backdrop while exceeding our expectations for operating margin improvement and customer wins. We continue to focus on our primary mission of powering all investment workflows with unparalleled technology, relentless innovation, and dedicated focus on our clients.”